Artificial interferons for treatment of infections
A German university offers chimeric mutants of interferon alpha 2 and other interferon alpha subtypes with improved antiviral activity for treatment of chronic or acute viral infections, bacterial or parasitic infections or tumour therapy. These interferons are characterized by a high biocompatibility. The university offers license agreements.